Clover Health Investments 株価情報 (NASDAQ: CLOV)

最新ニュース Clover Health Investments (NASDAQ:CLOV) 株価情報

Clover Health Investments

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

Clover Health Investments, Corp. - Class A Common stock

Clover Health Investments Corp

CLOVER CORP LTD by Clover Corporation Ltd.

CLOVER LEAF CAP CORP RT

Clover Finance - United States Dollar

Clover Leaf Capital Corp

Clover Leaf Capital Corp Units (1 Ord Share Class A & 1 Right)

CLOVERLEAF KENNEL CLB A by Cloverleaf Kennel Club

Cloverleaf Kennel Club

Clovis Oncology Inc

Toyota Motor Corp&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>) sports car lineup for 2026 includes the GR86 Yuzu Edition, which has a richer exterior color than its predecessor, the <a href="https://www.benzinga.com/pressreleases/25/04/n44639814/toyota-brightens-the-city-streets-with-new-gr86-yuzu-edition" target="_blank" rel="noreferrer noopener">Scion FR-S Release Series 1.0</a>, the company announced Thursday.
Based on the GR86 Premium grade, the special edition will feature 18-inch matte-black wheels and other stunning black accents throughout the vehicle.
On the inside, the Yuzu edition features a black interior with yellow accents.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/04/44607859/teslas-deliveries-slide-in-q1-amid-production-setbacks-political-backlash" rel="noreferrer noopener">Tesla&#8217;s Deliveries Slide In Q1 Amid Production Setbacks, Political Backlash</a>
Customers will find black Ultrasuede trimmed sport seats with yellow perforation and yellow stitching on the steering wheel, parking brake handle, and door trim.
Brembo Brakes improve stopping power, and SACHS Dampers provide additional stability while preserving GR86&#8217;s trademark playfulness. Customers can customize their vehicle by adding accessories like a cat-back exhaust with GR logo silver-colored tips and a body kit to the Yuzu edition for even more self-expression.
For the 2026 model year, the GR86 will be available in three grades: GR86, GR86 Premium, and the GR86 Yuzu edition. All grades will offer a choice of a six-speed manual or automatic transmission and be powered by a 2.4-liter, 4-cylinder boxer engine.&nbsp;
The GR86 will arrive at Toyota dealerships in the fall of 2025. In 2026, only 860 Yuzu editions will be assembled for the North American market.
In July 2024, Tesla CEO Elon Musk applauded Audi&#8217;s Auto Union Type 52 sports car, which is also called the Schnellsportwagen, equipped with a <a href="https://www.benzinga.com/news/24/07/40008880/audi-showcases-16-cylinder-engine-sports-car-based-on-90-year-old-concept-tesla-ceo-elon-musk-calls" target="_blank" rel="noreferrer noopener">16-cylinder engine</a> and painted Cellulose Silver.
Tesla&#8217;s debut vehicle was the Roadster, a battery-electric sports car. The company is now developing a new version, likely to&nbsp;start production in 2025. Musk said earlier this year that the new car can accelerate from 0 to 60 mph in less than 1 second, thanks to a collaboration between Tesla and SpaceX.
In October 2024, podcast host&nbsp;Joe Rogan&nbsp;appreciated Bugatti&#8217;s&nbsp;hybrid <a target="_blank" href="https://www.benzinga.com/news/24/10/41401069/joe-rogan-floored-by-bugattis-hybrid-sports-car-tourbillon-its-insane" rel="noreferrer noopener">sports car, the Tourbillon</a>.
Meanwhile, President Donald Trump&#8217;s newly imposed&nbsp;25% auto tariff&nbsp;threatens to disrupt the global automotive industry, with analysts warning of sharp price increases and declining sales.
Goldman Sachs&nbsp;projected <a target="_blank" href="https://www.benzinga.com/news/25/03/44522387/japanese-automakers-face-29-billion-tariff-hit-nissan-mazda-subaru-most-at-risk-says-analyst" rel="noreferrer noopener">imported&nbsp;vehicle prices</a> to rise by $5,000 to $15,000, while even U.S.-built cars could see cost hikes of $3,000 to $8,000 due to foreign-made parts.
According to JPMorgan&#8217;s Akira Kishimoto, Japanese automakers could face a potential hit of 4.46 trillion yen (about $29.44 billion). Given its resilience and strong fundamentals, Toyota remains JPMorgan&#8217;s top pick.
TM Price Action: Toyota stock is up slightly to $168.07 Friday morning at publication. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/04/44605125/uber-teams-up-with-weride-to-bring-self-driving-cars-to-dubai" target="_blank" rel="noreferrer noopener">Uber Teams Up With WeRide To Bring Self-Driving Cars To Dubai</a></li>
</ul>
Photo: GR86 Yuzu Edition courtesy Toyota

News

Toyota's GR86 Yuzu Edition Brings Sleek Design, Performance Upgrades; Only 860 Units Available In North America

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Citigroup cut Nordstrom, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JWN#NYSE">JWN</a>) price target from $25 to $22. Citigroup analyst Paul Lejuez downgraded the stock from Neutral to Sell. Nordstrom shares closed at $23.96 on Thursday. See how other analysts <a href="https://www.benzinga.com/quote/JWN/analyst-ratings">view this stock</a>.</li>
<li>Baird slashed the price target for BRP Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOOO#NASDAQ">DOOO</a>) from $48 to $43. Baird analyst Craig Kennison downgraded the stock from Outperform to Neutral. BRP shares closed at $35.38 on Thursday. <a href="https://www.benzinga.com/quote/DOOO/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays raised ADT Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADT#NYSE">ADT</a>) price target from $7 to $9. Barclays analyst Manav Patnaik upgraded the stock from Underweight to Equal-Weight. ADT shares closed at $8.08 on Thursday. See how other analysts view<a href="https://www.benzinga.com/quote/ADT/analyst-ratings"> this stock</a>.</li>
<li>JP Morgan cut the price target for LyondellBasell Industries N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>) from $80 to $60. JP Morgan analyst Jeffrey Zekauskas downgraded the stock from Overweight to Neutral. LyondellBasell shares closed at $63.11 on Thursday. <a href="https://www.benzinga.com/quote/LYB/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham cut the price target for Montrose Environmental Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEG#NYSE">MEG</a>) from $39 to $28. Needham analyst James Ricchiuti maintained a Buy rating. Montrose Environmental shares closed at $12.20 on Thursday. See how other analysts view this stock.</li>
<li>HC Wainwright &amp; Co. cut I-Mab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMAB#NASDAQ">IMAB</a>) price target from $8 to $7. HC Wainwright &amp; Co. analyst Andrew Fein maintained a Buy rating. I-Mab shares settled at $0.7301 on Thursday. <a href="https://www.benzinga.com/quote/IMAB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Rosenblatt cut Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) price target from $115 to $85. Rosenblatt analyst Mike Genovese upgraded the stock from Neutral to Buy. Coherent shares closed at $53.91 on Thursday. <a href="https://www.benzinga.com/quote/COHR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Citigroup slashed Eastman Chemical Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) price target from $105 to $101. Citigroup analyst Patrick Cunningham upgraded the stock from Neutral to Buy. Eastman Chemical shares closed at $79.98 on Thursday.  <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird slashed the price target for LCI Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LCII#NYSE">LCII</a>) from $130 to $100. Baird analyst Craig Kennison downgraded the stock from Outperform to Neutral. LCI Industries shares settled at $81.00 on Thursday. <a href="https://www.benzinga.com/quote/LCII/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird cut MasterCraft Boat Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCFT#NASDAQ">MCFT</a>) price target from $26 to $20. Baird analyst Craig Kennison downgraded the stock from Outperform to Neutral. MasterCraft Boat shares closed at $16.41 on Thursday. <a href="https://www.benzinga.com/quote/MCFT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying ADT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="611" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04085201/image-48-1024x611.png" alt="" class="wp-image-857531" style="width:488px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04085201/image-48-1024x611.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04085201/image-48-300x179.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04085201/image-48-768x458.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04085201/image-48.png 1098w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/25/04/44641655/guess-simulations-plus-and-3-stocks-to-watch-heading-into-friday">Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday</a> </li>
</ul>
Photo via Shutterstock

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

COHR

DOOO

IMAB

LCII

MCFT

ADT To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Friday

Baird analyst Craig Kennison downgrades Thor Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THO#NYSE">THO</a>) from Outperform to Neutral and lowers the price target from $100 to $85.

Downgrades

Baird Downgrades Thor Industries to Neutral, Lowers Price Target to $85

William Blair analyst Dylan Carden initiates coverage on Savers Value Village (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SVV#NYSE">SVV</a>) with a Outperform rating.

Initiation

William Blair Initiates Coverage On Savers Value Village with Outperform Rating

Baird analyst Craig Kennison downgrades RumbleON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>) from Outperform to Neutral and lowers the price target from $5 to $3.

RMBL

Baird Downgrades RumbleON to Neutral, Lowers Price Target to $3

<a href="https://img1.wsimg.com/blobby/go/cc91fda7-4669-4d1b-81ce-a0b8d77f25ab/downloads/c7d21803-e1e5-4a88-8740-7465b3f25ad0/Culper_GRRR_4-4-2025.pdf?ver=1743770140803" title="https://img1.wsimg.com/blobby/go/cc91fda7-4669-4d1b-81ce-a0b8d77f25ab/downloads/c7d21803-e1e5-4a88-8740-7465b3f25ad0/Culper_GRRR_4-4-2025.pdf?ver=1743770140803">https://img1.wsimg.com/blobby/go/cc91fda7-4669-4d1b-81ce-a0b8d77f25ab/downloads/c7d21803-e1e5-4a88-8740-7465b3f25ad0/Culper_GRRR_4-4-2025.pdf?ver=1743770140803</a>

Short Sellers

GRRR

Watching Gorilla Technology; Culper Research Issues Short Report On Co

Baird analyst Craig Kennison downgrades Patrick Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PATK#NASDAQ">PATK</a>) from Outperform to Neutral and lowers the price target from $100 to $96.

PATK

Baird Downgrades Patrick Industries to Neutral, Lowers Price Target to $96

Citigroup analyst Spiro Dounis initiates coverage on Enbridge (CSE2: ENB) with a Buy rating and announces Price Target of C$75.

Citigroup Initiates Coverage On Enbridge with Buy Rating, Announces Price Target of C$75

<a href="https://www.globenewswire.com/Tracker?data=VxHo1_SeeSOuaURybab7ked29qE8ezMZodvTjLAvq_Kg9d4AUSOr1SJKUM6OgiyjgYMu4e1R2PjJUryKu50XfXQfoqDwRZvsqzAUQY0B8Ie44KmsQdo8EJ8ee99tsoG_uCWOsd9ebAUapgCgfmYxHg==">American Battery Technology Company&nbsp;</a>(ABTC) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABAT#NASDAQ">ABAT</a>), an integrated critical battery materials company that is commercializing its technologies for both primary battery minerals manufacturing and secondary minerals lithium-ion battery recycling, has announced the sale of one of its unused legacy properties located at 395 Logan Lane in Fernley, Nevada. This 12-acre property entered into contract to sell for $6.75 million, with the transaction expected to close on or before July 10, 2025. &nbsp;
This strategic sale will support the company's mission to advance its lithium-ion battery recycling technologies and streamlined operations at its commercial-scale battery recycling facility in the Tahoe-Reno Industrial Center (TRIC) at 2500 Peru Drive, McCarran, Nevada. The prioritization of this operational facility at TRIC allows ABTC to continue its focused implementation on its innovative recycling processes that are critical to developing a domestic supply of refined battery materials.

Contracts

Asset Sales

ABAT

American Battery Technology Announces $6.75M Sale Of Legacy Property In Fernley, Nevada, To Support Advancements In Lithium-Ion Battery Recycling And Operations At TRIC Facility

As Wall Street crumbles from the impact of tariffs, cracks are still not visible in the U.S. labor market, which continues to show resilience and defies investor <a href="https://www.benzinga.com/news/econ-s">fears of economic weakness.</a> 
In March, nonfarm payrolls surged by 228,000, the Bureau of Labor Statistics reported Friday. The outcome is well above the three-month average of 195,000 and topped economists' forecasts of 135,000. February&#8217;s employment growth was downwardly revised to 117,000. 
Private sector payrolls surged by 209,000, the highest since December 2024. Employment rose in health care, social assistance, and transportation and warehousing. Retail trade also saw job gains, partly due to the return of workers following a strike.
Public sector payrolls surprisingly rose by 19,000, slightly quelling fears of DOGE-related layoffs filtering into the data. 
Meanwhile, the unemployment rate unexpectedly inched higher from 4.1% to 4.2%, defying expectations for no change.
Wage growth broadly matched expectations. Average hourly earnings increased 0.3% from February's pace, as predicted, and rose 3.8% year-over-year, marginally lower than the 3.9% predicted.
<h3 class="wp-block-heading">Market Reactions</h3>
Markets were already in a state of extreme volatility ahead of Friday's jobs report, as tensions escalated between the U.S. and China.
Beijing unveiled a retaliatory 34% tariff on U.S. goods—mirroring the rate announced by President Donald Trump on Wednesday—deepening fears of a full-blown trade war.
Futures tied to the S&amp;P 500—tracked via the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)—slid 2.5% by 8:35 a.m. ET, following a 4.9% rout the previous day.
Nasdaq 100 futures dropped 2.6%, putting the tech-heavy index on course for its sixth consecutive weekly loss. The VIX – also known as &#8220;market fear gauge&#8221; – was up 34%. 
U.S. Treasury yields tumbled as investors fled to safe-haven assets. The yield on the 10-year note fell 15 basis points to 3.88%, marking its lowest level since late September 2024.
Rate cut bets gained traction. Traders now assign a 40% probability to the Federal Reserve lowering interest rates as soon as May, according to the CME FedWatch Tool. Yet, they see June as the most likely month for the next rate cut, applying a 100% likelihood.
Investors now await remarks from Fed Chair Jerome Powell, who will hit the wires at 11:25 a.m. on Friday. 
Read now: 
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/04/44643100/us-stocks-likely-to-open-lower-after-the-worst-selloff-since-2020-tariff-announcement-was-100-smoot-hawley-disguised-as-thoughtful-policy-says-expert">Stocks Set To Continue Crashing After Worst Selloff Since 2020: Tariff Announcement Was &#8216;100% Smoot Hawley Disguised As Thoughtful Policy,&#8217; Says Expert</a></li>
</ul>
Photo: Shutterstock

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

Economics

Federal Reserve

ETFs

Strong Jobs Report Offers Hope — But Will It Be Enough To Counter Tariff Turmoil?

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
<h3 class="wp-block-heading">Bristol-Myers Squibb Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>)</h3>
<ul>
<li>Dividend Yield: 4.29%</li>
<li>Wells Fargo analyst Mohit Bansal maintained an Equal-Weight rating and raised the price target from $60 to $62 on Feb. 7, 2025. This analyst has an accuracy rate of 71%.</li>
<li>Citigroup analyst Andrew Baum maintained a Neutral rating and raised the price target from $60 to $65 on Jan. 28, 2025. This analyst has an accuracy rate of 71%.</li>
<li>Recent News: On March 24, Bristol Myers Squibb received positive CHMP opinion for subcutaneous formulation of Opdiv across multiple solid tumor indications.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0404">latest BMY news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0404"><img loading="lazy" decoding="async" width="906" height="817" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045052/image-43.png" alt="" class="wp-image-857124" style="width:554px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045052/image-43.png 906w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045052/image-43-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045052/image-43-768x693.png 768w" sizes="(max-width: 906px) 100vw, 906px" /></a></figure>
<h3 class="wp-block-heading">DENTSPLY SIRONA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRAY#NASDAQ">XRAY</a>)</h3>
<ul>
<li>Dividend Yield: 4.70%</li>
<li>Morgan Stanley analyst Erin Wright maintained an Overweight rating and cut the price target from $30 to $23 on Dec. 17, 2024. This analyst has an accuracy rate of 75%.</li>
<li>UBS analyst Kevin Caliendo maintained a Buy rating and cut the price target from $35 to $27 on Dec. 3, 2024. This analyst has an accuracy rate of 72%.</li>
<li>Recent News: On March 17, Dentsply Sirona named David Ferguson as Global Business Unit Leader.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest XRAY <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0404">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0404"><img loading="lazy" decoding="async" width="910" height="818" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045120/image-1-13.png" alt="" class="wp-image-857125" style="width:555px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045120/image-1-13.png 910w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045120/image-1-13-300x270.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045120/image-1-13-768x690.png 768w" sizes="(max-width: 910px) 100vw, 910px" /></a></figure>
<h3 class="wp-block-heading">Viatris Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTRS#NASDAQ">VTRS</a>)</h3>
<ul>
<li>Dividend Yield: 5.88%</li>
<li>Piper Sandler analyst David Amsellem reiterated a Neutral rating and raised the price target from $13 to $14 on Dec. 6, 2024. This analyst has an accuracy rate of 73%.</li>
<li>B of A Securities analyst Jason Gerberry downgraded the stock from Neutral to Underperform with a price target of $9 on Oct. 23, 2024. This analyst has an accuracy rate of 62%.</li>
<li>Recent News: Viatris will report first quarter financial results on Thursday, May 8.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest VTRS <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0404">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0404"><img loading="lazy" decoding="async" width="913" height="820" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045307/image-1-14.png" alt="" class="wp-image-857127" style="width:526px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045307/image-1-14.png 913w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045307/image-1-14-300x269.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045307/image-1-14-768x690.png 768w" sizes="(max-width: 913px) 100vw, 913px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44641655/guess-simulations-plus-and-3-stocks-to-watch-heading-into-friday">Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday</a> </li>
</ul>
Photo via Shutterstock

Dividends

VTRS

XRAY

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields

Baird analyst Craig Kennison downgrades OneWater Marine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEW#NASDAQ">ONEW</a>) from Outperform to Neutral and lowers the price target from $25 to $18.

ONEW

Baird Downgrades OneWater Marine to Neutral, Lowers Price Target to $18

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Barclays analyst Manav Patnaik upgraded the rating for ADT Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADT#NYSE">ADT</a>) from Underweight to Equal-Weight and raised the price target from $7 to $9. ADT shares closed at $8.08 on Thursday. <a href="https://www.benzinga.com/quote/ADT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Rosenblatt analyst Mike Genovese upgraded Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) from Neutral to Buy and lowered the price target from $115 to $85. Coherent shares closed at $53.91 on Thursday. <a href="https://www.benzinga.com/quote/COHR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst James Hardiman upgraded BRP Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOOO#NASDAQ">DOOO</a>) from Sell to Neutral and raised the price target from $27 to $37. BRP shares closed at $35.38 on Thursday. <a href="https://www.benzinga.com/quote/DOOO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Ben Gerlinger upgraded Flagstar Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLG#NYSE">FLG</a>) from Neutral to Buy and raised the price target from $13.5 to $15. Flagstar Financial shares closed at $10.79 on Thursday. <a href="https://www.benzinga.com/quote/flg/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Patrick Cunningham upgraded Eastman Chemical Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) from Neutral to Buy and lowered the price target from $105 to $101. Eastman Chemical shares closed at $79.98 on Thursday.  <a href="https://www.benzinga.com/quote/emn/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying ADT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="594" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04081750/image-46-1024x594.png" alt="" class="wp-image-857450" style="width:547px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04081750/image-46-1024x594.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04081750/image-46-300x174.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04081750/image-46-768x445.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04081750/image-46.png 1092w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44641655/guess-simulations-plus-and-3-stocks-to-watch-heading-into-friday">Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday</a> </li>
</ul>
Photo via Shutterstock

Upgrades

EDAP

This Eastman Chemical Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Baird analyst Craig Kennison downgrades MasterCraft Boat Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCFT#NASDAQ">MCFT</a>) from Outperform to Neutral and lowers the price target from $26 to $20.

Baird Downgrades MasterCraft Boat Hldgs to Neutral, Lowers Price Target to $20

WIIM

PAMT

PAMT CORP shares are trading higher after the company announced it will repurchase 435K shares of common stock.

Citigroup analyst Spiro Dounis initiates coverage on TC Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TRP#TSX">TRP</a>) with a Neutral rating and announces Price Target of C$75.

TSX:TRP

Citigroup Initiates Coverage On TC Energy with Neutral Rating, Announces Price Target of C$75

LNZA

LanzaTech Global shares are trading lower. The company announced it received a $0.02 per share takeover offer from Carbon Direct Capital.

Baird analyst Craig Kennison downgrades Malibu Boats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBUU#NASDAQ">MBUU</a>) from Outperform to Neutral and lowers the price target from $50 to $32.

MBUU

Baird Downgrades Malibu Boats to Neutral, Lowers Price Target to $32

Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) will release its first-quarter earnings results after the <a href="https://www.benzinga.com/quote/LEVI/earnings">closing bell on Monday, April 7</a>.
Analysts expect the company to report quarterly earnings at 28 cents per share. That&#8217;s up from 26 cents per share in the year-ago period. According to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro</a>, Levi Strauss projects quarterly revenue at $1.54 billion, compared to $1.56 billion a year earlier.
On Wednesday, Telsey Advisory Group analyst Dana Telsey maintained Levi Strauss with an Outperform rating and maintained a $23 price target.
With the recent buzz around Levi Strauss, some investors may be eyeing potential gains from the company's dividends. Currently, Levi Strauss offers an annual dividend yield of 3.60% and a quarterly dividend of 13 cents per share (52 cents a year).  
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $166,623 or around 11,539 shares. For a more modest $100 per month or $1,200 per year, you would need $33,328 or around 2,308 shares.
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($0.52 in this case). So, $6,000 / $0.52 = 11,539 ($500 per month), and $1,200 / $0.52 = 2,308 shares ($100 per month).
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock&#8217;s current price.
For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
LEVI Price Action: Shares of Levi Strauss fell 13.7% to close at $14.44 on Thursday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44626468/top-3-risk-off-stocks-that-are-ticking-portfolio-bombs">Top 3 Risk Off Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>
Image: Shutterstock

Earnings

Long Ideas

LEVI

How To Earn $500 A Month From Levi Strauss Stock Ahead Of Q1 Earnings

On Friday, AerCap Holdings N.V. (AER) announced key first-quarter 2025 <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n44643706/aercap-leased-purchased-and-sold-203-assets-in-the-first-quarter-2025" rel="noreferrer noopener">financial and operational performance updates</a>.
Asset Transactions: The company signed 112 lease agreements, including four widebody and 47 narrowbody aircraft, 42 engines and 19 helicopters. It also completed 49 acquisitions (13 aircraft, 35 engines, one helicopter) and finalized 42 sales (29 aircraft, 11 engines, two helicopters). ​
Financial Activities: AerCap secured financing transactions totaling approximately $1.5 billion and repurchased 5.7 million shares at an average price of $97.93 per share, amounting to $558 million.​
Dividend Declaration: The company declared a quarterly cash dividend of $0.27 per share.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/25/03/44431541/malaysia-aviation-group-orders-30-boeing-737-max-jets-secures-option-for-30-more-amid-rising-southeast-asia-demand" rel="noreferrer noopener">Malaysia Aviation Group Orders 30 Boeing 737 MAX Jets, Secures Option For 30 More Amid Rising Southeast Asia Demand</a>
Last month, amid escalating trade tensions, AerCap CEO Aengus Kelly <a href="https://www.benzinga.com/markets/25/03/44296119/boeing-787-prices-could-jump-by-40m-in-worst-case-scenario-amid-trump-tariffs-warns-aercap-chief" target="_blank" rel="noreferrer noopener">warned</a> that tariffs could raise Boeing 787 costs by $40 million, potentially benefiting Airbus, which is better positioned to withstand tariff impacts.
Price Action: AER shares are trading lower by 2.91% at $95.78 premarket on the last check on Friday.
Photo: Shutterstock

Comments

Clover Health Investments

ニュース

最新ニュース Clover Health Investments (NASDAQ:CLOV) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル